0759 Phase 2 Proof Of Concept Study Of SUVN-G3031, A Histamine H3 Receptor Inverse Agonist For The Potential Treatment Of Narcolepsy von Nirogi, R, Goyal, V, Jayarajan, P, Bhyrapuneni, G, Ravula, J, Jetta, S, Shinde, A

Volltext

0008 SUVN-G3031, A Histamine H3 Receptor Inverse Agonist Produces Robust Wake Promoting and Anticataplectic Activity in Orexin Knockout Mice von Benade, V, Daripelli, S, Petlu, S, Subramanian, R, Bhyrapuneni, G, Shinde, A, Rasheed, M, Jayarajan, P, Choudakari, P, Nirogi, R

Volltext

SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of narcolepsy with or without cataplexy – Differentiating factors with competitor clinica... von Nirogi, R., Bhyrapuneni, G., Abraham, R., Subramanian, R., Goyal, V.K., Pandey, S.K., Badange, R., Shinde, A.

Volltext

Mechanistic evaluation of tapentadol in reducing the pain perception using in-vivo brain and spinal cord microdialysis in rats von Benade, Vijay, Nirogi, Ramakrishna, Bhyrapuneni, Gopinadh, Daripelli, Saivishal, Ayyanki, Ganesh, Irappanavar, Shantaveer, Ponnamaneni, Ranjithkumar, Manoharan, Arunkumar

Volltext

0760 SUVN-G3031, A Potent And Selective Histamine H3 Receptor Inverse Agonist: Safety, Tolerability And Pharmacokinetics Following Single And Multiple Ascending Doses In Healthy Ad... von Bhyrapuneni, G, Goyal, V, Pandey, S, Muddana, N, Palacharla, R, Ajjala, D, Ravula, J, Jetta, S, Badange, R, Benade, V, Nirogi, R

Volltext

Safety, tolerability and pharmacokinetics of a potent and selective histamine h3 receptor inverse agonist, SUVN-G3031 following single and multiple ascending doses in healthy subje... von Nirogi, R., Mudigonda, K., Bhyrapuneni, G., Muddana, N.R., Palacharla, R.C., Ajjala, D.R., Goyal, V.K., Ravula, J., Jetta, S., Mohammed, A.R., Shinde, A.

Volltext